Skip to Main Content

Author Archives: Sonia Canzater

09.29.16

O’Neill Institute Hosts Meeting to discuss improving Hepatitis C data collection and surveillance

By Sonia Canzater

On September 19th, the Hepatitis C Policy Project hosted a meeting at the Georgetown University Law Center in Washington, DC to discuss strategies to improve data collection and case surveillance for Hepatitis C in the United States. Thought leaders from a range of public health backgrounds, – including physicians, patient advocates, researchers and federal agency directors […]

Thematic Areas:

08.08.16

Spike in hepatitis C rates in young women further supports the need for screenings for all pregnant women

By Sonia Canzater

As the rate of Hepatitis C infections among young Americans increases, so does the risk of infections in infants. The CDC reports a 22% increase between 2011 and 2014  in HCV infections in women of childbearing age, between 15-44 years.  There was also a 14% increase in infections in children 2 years and younger seen during […]

Tags:
Thematic Areas:

07.08.16

Viral Hepatitis is the seventh leading cause of death worldwide: Yet U.S. treatment interventions continue to go underfunded

By Sonia Canzater

An article published on July 6, 2016 in The Lancet ranks viral hepatitis infections – specifically both Hepatitis B (HBV) and Hepatitis C (HCV) – as the seventh leading cause of death worldwide in 2013, up from tenth in 1990. Where other infectious diseases such as tuberculosis, malaria and diarrheal diseases saw sharp declines over this timespan, HBV […]

Tags:
Thematic Areas:

06.08.16

Litigation is forcing States to finally stop restricting Hepatitis C treatment for Medicaid recipients

By Sonia Canzater

Last week, a federal judge in Washington State ruled that the state Medicaid authority cannot place undue limitations on access to Hepatitis C (HCV) drugs for patients, as Medicaid has the duty to provide “medically necessary” treatment to the patients it covers. Until this ruling, many states, including Washington, citing the high cost of the […]

Categories:
Tags:
Thematic Areas:

05.05.16

May is National Hepatitis Awareness Month: Hepatitis C testing is critically important as CDC reports infection rates and deaths in U.S. at all-time high

By Sonia Canzater

May is National Hepatitis Awareness Month. The CDC has designated May 19th, 2016 as National Hepatitis Testing Day in the U.S. This campaign is particularly timely this year given the report released this Wednesday by the CDC  which states that new infections and deaths caused by Hepatitis C (HCV) are at the highest rates ever reported. […]

Thematic Areas:

04.05.16

HHS guidance on syringe service programs provides substantive support for HCV and HIV infection reduction efforts among injection drug users.

By Sonia Canzater

On March 29, 2016, the Department of Health and Human Services released guidance to assist state and local health departments to request permission to use federal funds for Syringe Support Programs (SSPs). This guidance is in response to bipartisan legislation passed in December 2015 that relaxed previous restrictions on federal funds being used for any […]

Thematic Areas:

02.10.16

FY 2017 Federal budget proposal addresses Hepatitis C epidemic, but misses opportunity to reach many at highest risk for infection

By Sonia Canzater

  Yesterday the White House released the proposed budget for fiscal year 2017. It includes a $5 million funding increase to the CDC and a $9 million increase to HRSA to support viral hepatitis prevention and treatment initiatives, with an emphasis on addressing the Hepatitis C epidemic. The $5 million at CDC will fund increased efforts […]

Thematic Areas:

01.12.16

The Promise and Pitfalls of Eradicating Hepatitis C

By Sonia Canzater

Hepatitis C is a contagious, bloodborne viral infection that causes inflammation in the liver. Many people with Hepatitis C are unaware of their infection because they can remain asymptomatic for years. However, if left untreated, a chronic Hepatitis C infection can cause severe scarring of the liver – called cirrhosis – liver cancer or death. […]

Tags:
Thematic Areas:

The views reflected in this expert column are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.